Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
After hours: January 31 at 4:20:00 PM EST Loading Chart for CLDX ...
Dyne Therapeutics Inc. 4.43% $1.38B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback